Literature DB >> 2558802

Binding sites for brain trace amines.

T V Nguyen1, A V Juorio.   

Abstract

1. Neurochemical, neuropharmacological, and neurophysiological studies suggest that some of the so-called trace amines may have a role in the modulation of neurotransmission. This review examines the possible existence and characterization of brain binding sites for the trace amines. 2. The results of radioligand binding studies carried out so far suggest the existence of tryptamine binding sites that possibly constitute a true functional receptor. This is supported by evidence obtained from the saturation studies, drug-mediated inhibition of binding, and the changes in the number of sites induced by pharmacological and lesion studies. In addition, the existence of a functional tryptamine binding site is supported by the increased neurophysiological responses of tryptamine obtained from the striatum of rat with unilateral substantia nigra lesions. 3. It has been shown that the brain contains saturable binding sites for rho-tyramine that appear to be related to the transport of dopamine into synaptic vesicles. There are, however, some questions with respect to the homogenization technique employed and some inconsistencies with respect to the number of binding sites estimated in neuronal membrane preparations. 4. The existence of rho-octopamine binding sites has been demonstrated in crude membranes obtained from fruitflies but not shown so far in vertebrates. 5. The presence of brain binding sites for beta-phenylethylamine are suggested but they are not so well defined and its physiological implication remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558802     DOI: 10.1007/BF00711411

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  51 in total

1.  Letter: Amines and theories in psychiatry.

Authors:  A A Boulton
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

2.  Distribution and metabolism of tryptamine in rat brain.

Authors:  P H Wu; A A Boulton
Journal:  Can J Biochem       Date:  1973-07

3.  The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.

Authors:  S R Philips; A A Boulton
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

4.  Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions.

Authors:  P J Conn; E Sanders-Bush
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

5.  The effects of some antipsychotic drugs, D-amphetamine, and reserpine on the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum.

Authors:  A V Juorio
Journal:  Can J Physiol Pharmacol       Date:  1982-03       Impact factor: 2.273

6.  Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.

Authors:  L L Martin; D M Roland; R F Neale; P L Wood
Journal:  Eur J Pharmacol       Date:  1986-12-02       Impact factor: 4.432

7.  The distribution and turnover of tryptamine in the brain and spinal cord.

Authors:  A V Juorio; D A Durden
Journal:  Neurochem Res       Date:  1984-09       Impact factor: 3.996

8.  Multiple receptor types for octopamine in the locust.

Authors:  P D Evans
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

9.  High-affinity octopamine receptors revealed in Drosophila by binding or [3H]octopamine.

Authors:  Y Dudai
Journal:  Neurosci Lett       Date:  1982-02-12       Impact factor: 3.046

10.  Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain.

Authors:  P Kaulen; G Brüning; H Rommelspacher; H G Baumgarten
Journal:  Brain Res       Date:  1986-02-26       Impact factor: 3.252

View more
  9 in total

Review 1.  Trace amine-associated receptors and their ligands.

Authors:  R Zucchi; G Chiellini; T S Scanlan; D K Grandy
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

2.  Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.

Authors:  T V Nguyen; A V Juorio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

3.  Investigations into the biochemical basis of neuromodulation by 2-phenylethylamine: effect on microtubule protein.

Authors:  M E Knight; J Harris
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

Review 4.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

Review 5.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

6.  Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.

Authors:  D D Mousseau; D J McManus; G B Baker; A V Juorio; W G Dewhurst; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1993-02       Impact factor: 5.046

Review 7.  2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

8.  Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord.

Authors:  Elizabeth A Gozal; Brannan E O'Neill; Michael A Sawchuk; Hong Zhu; Mallika Halder; Ching-Chieh Chou; Shawn Hochman
Journal:  Front Neural Circuits       Date:  2014-11-07       Impact factor: 3.492

Review 9.  Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.

Authors:  Yue Pei; Aman Asif-Malik; Juan J Canales
Journal:  Front Neurosci       Date:  2016-04-05       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.